Presentation and Status in Health Basket
| Presentation | Basket | Yarpa | Pharmasoft |
|---|---|---|---|
|
Vial 10 X 10 ml |
|
Dosage
PEDITRACE must not be given undiluted.
The recommended dose is 1 ml PEDITRACE/kg body weight/day for infants and children with a weight of up to 15 kg. The basic requirements of trace elements are covered by a daily dose of 15 ml to children weighing more than 15 kg.
Indications
Peditrace is indicated to meet the basal requirement of trace elements during intravenous nutrition of infants and children.
Contra-Indications
Wilson’s Disease.
Special Precautions
This product should be used with caution in patients with impaired biliary and/or renal function, in whom the excretion of trace elements may be significantly decreased. It should also be used with caution in patients with biochemical or clinical evidence of liver dysfunction
(especially cholestasis). If the treatment is continued for more than 4 weeks, checking of manganese levels is required.
Patients with increased losses or requiring prolonged intravenous nutrition should be monitored biochemically to
confirm the requirements are being met appropriately.
Side Effects
No adverse effects related to the trace elements in this product have been reported.
Superficial thrombophlebitis has been observed when glucose containing was given. However, it is not possible to deduce whether this reaction is attributable to the trace elements infusion or not. Allergic reactions to iodine may occur following topical application. No adverse reactions are known to occur as a consequence of using the recommended intravenous iodide dosage levels.
Drug interactions
No interactions with other drugs have been observed.
Pregnancy and Lactation
Not applicable.
Overdose
In patients with impaired renal or biliary function, there is an increased risk for accumulation of trace elements.
